Furiex Pharmaceuticals, Inc. (FURX) Misses Q2 EPS by 67c
Tweet Send to a Friend
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
